These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 27822011)

  • 1. Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway.
    Wu S; Zhang T; Du J
    Drug Des Devel Ther; 2016; 10():3471-3481. PubMed ID: 27822011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
    Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
    Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the NRF2-ARE signalling pathway by the Lentinula edodes polysaccharose LNT alleviates ROS-mediated cisplatin nephrotoxicity.
    Chen Q; Peng H; Dong L; Chen L; Ma X; Peng Y; Dai S; Liu Q
    Int Immunopharmacol; 2016 Jul; 36():1-8. PubMed ID: 27093515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 mediates the resistance of human A549 and HepG2 cancer cells to boningmycin, a new antitumor antibiotic, in vitro through regulation of glutathione levels.
    Zhang HX; Chen Y; Xu R; He QY
    Acta Pharmacol Sin; 2018 Oct; 39(10):1661-1669. PubMed ID: 30287928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astaxanthin and omega-3 fatty acids individually and in combination protect against oxidative stress via the Nrf2-ARE pathway.
    Saw CL; Yang AY; Guo Y; Kong AN
    Food Chem Toxicol; 2013 Dec; 62():869-75. PubMed ID: 24157545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells.
    Kim H; Ramirez CN; Su ZY; Kong AN
    J Nutr Biochem; 2016 Jul; 33():54-62. PubMed ID: 27260468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway.
    Xia C; Bai X; Hou X; Gou X; Wang Y; Zeng H; Huang M; Jin J
    Cell Physiol Biochem; 2015; 37(2):816-24. PubMed ID: 26356271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer-bound Nrf2 licenses HIF-1α transcription under hypoxia to promote cisplatin resistance in hepatocellular carcinoma cells.
    Jin X; Gong L; Peng Y; Li L; Liu G
    Aging (Albany NY); 2020 Dec; 13(1):364-375. PubMed ID: 33290263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
    Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
    Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of cyanidin-3-O-glucoside and cisplatin induces oxidative stress and apoptosis in HeLa cells by reducing activity of endogenous antioxidants, increasing bax/bcl-2 mRNA expression ratio, and downregulating Nrf2 expression.
    Li X; Mu J; Lin Y; Zhao J; Meng X
    J Food Biochem; 2021 Jul; 45(7):e13806. PubMed ID: 34080212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
    Kim EH; Jang H; Shin D; Baek SH; Roh JL
    Apoptosis; 2016 Nov; 21(11):1265-1278. PubMed ID: 27544755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway.
    Chian S; Zhao Y; Xu M; Yu X; Ke X; Gao R; Yin L
    Anticancer Drugs; 2019 Sep; 30(8):838-845. PubMed ID: 31415285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geraniin exerts cytoprotective effect against cellular oxidative stress by upregulation of Nrf2-mediated antioxidant enzyme expression via PI3K/AKT and ERK1/2 pathway.
    Wang P; Peng X; Wei ZF; Wei FY; Wang W; Ma WD; Yao LP; Fu YJ; Zu YG
    Biochim Biophys Acta; 2015 Sep; 1850(9):1751-61. PubMed ID: 25917210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
    Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK
    Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway.
    Chian S; Li YY; Wang XJ; Tang XW
    Asian Pac J Cancer Prev; 2014; 15(6):2911-6. PubMed ID: 24761924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis.
    Wang J; Jiang Z; Xiang L; Li Y; Ou M; Yang X; Shao J; Lu Y; Lin L; Chen J; Dai Y; Jia L
    Sci Rep; 2014 May; 4():5006. PubMed ID: 25833312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tussilagonone-induced Nrf2 pathway activation protects HepG2 cells from oxidative injury.
    Lee KM; Kwon TY; Kang U; Seo EK; Yun JH; Nho CW; Kim YS
    Food Chem Toxicol; 2017 Oct; 108(Pt A):120-127. PubMed ID: 28733231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.